Newstral
AstraZeneca
- AstraZeneca’s breast cancer trial shows ‘unprecedented’ resultsstaradvertiser.com
- NIH scientists made $710M in royalties from drug makers — a fact they tried to hideNew York Post
- CNO MORE FEAR AND LOATHING OF SPINOUTSceoworld.biz
- Scientists develop antibiotic that spares healthy gut bacteriaShropshire Star
- SThailand’s free healthcare system is overworking its doctors. Can AI alleviate the burden?scmp.com
- SAstraZeneca’s Jab Ends; Officials Urge Getting Covid Boosterssampan.org
- ‘Lives will be cut short’ if drug not given to women with breast cancerexpressandstar.com
- The First Biosimilar Disputes at the Unified Patent Court (UPC)jdsupra.com
- Language app Pratika raises a $35.5M Series A roundtech.eu
- AstraZeneca PLC: AstraZeneca to build Chinese supply chain as US-Sino tensions increaseFinancial Times
- Ipilimumab, a Pioneer Breakthrough in Cancer TreatmentForbes
- AstraZeneca PLC: AstraZeneca to build $1.5bn manufacturing site in SingaporeFinancial Times
- AstraZeneca to build US$1.5 billion cancer drug plant in Singapore, reduce industry’s reliance on ChinaSouth China Morning Post
- 'Poorly designed': ICMR distances itself from BHU's Covaxin studyThe Times of India
- TOI health news morning briefingThe Times of India
- Reps. Jim Jordan, Thomas Massie threaten CDC subpoena for vaccine efficacy dataNew York Post
- CBanning Non-Competes: Great News For Spinout Entrepreneursceoworld.biz
- TThe future of the Royal Mail is not just a matter for the current owners, says ALEX BRUMMERthisismoney.co.uk
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.